Related Experiment Video
Updated: Jul 31, 2026
09:45
Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
10.2K
Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease
T Vinther-Jensen1,2, A H Simonsen1, E Budtz-Jørgensen3
1Department of Neurology, Danish Dementia Research Centre, Neurogenetics Clinic, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
European Journal of Neurology
|June 16, 2015
Summary
Researchers identified ubiquitin in cerebrospinal fluid as a potential biomarker for Huntington's disease progression. This finding may help track disease severity and inform therapeutic interventions.
Area of Science:
- Neuroscience
- Biochemistry
- Proteomics
Background:
- Identifying early and dynamic biomarkers is crucial for understanding Huntington's disease (HD) pathology and progression.
- Biomarkers aid in evaluating neuroprotective therapies and determining optimal intervention timing.
Purpose of the Study:
- To explore potential cerebrospinal fluid (CSF) biomarkers for Huntington's disease.
- To investigate the role of the ubiquitin-proteasome system in HD pathogenesis.
Main Methods:
- Proteomics analysis of CSF using surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry.
- Evaluated 94 Huntington's disease gene-expansion carriers (premanifest and manifest) and 27 controls.
Main Results:
- 10 protein peaks showed statistically significant differences between manifest HD carriers and controls.
- Ubiquitin levels correlated with disease severity measures (Unified Huntington Disease Rating Scale Total Functional Capacity, Symbol Digit Modalities Test) and CAG-age product score.
Conclusions:
- This study confirms the involvement of the ubiquitin-proteasome system in Huntington's disease CSF.
- Elevated ubiquitin levels correlate with disease progression and CAG-age product score.
- Ubiquitin shows potential as a Huntington's disease progression marker, even before motor symptom onset.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...